quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:00:00·1675d
PRRelease
Hancock Jaffe Laboratories, Inc. logo

Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs

HJLI· Hancock Jaffe Laboratories, Inc.
Health Care
Original source

Companies

  • HJLI
    Hancock Jaffe Laboratories, Inc.
    Health Care

Related

  • SEC1665d
    Hancock Jaffe Laboratories, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
  • PR1665d
    enVVeno Medical Corporation Successfully Completes Rebranding
  • PR1672d
    Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann
  • SEC1674d
    Hancock Jaffe Laboratories, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • 13D/G1679d
    SEC Form SC 13G filed by Hancock Jaffe Laboratories, Inc.
  • INSIDER1681d
    SEC Form 4: Gray Robert converted options into 1,042 units of Common Stock, increasing direct ownership by 19% to 6,614 units
  • INSIDER1681d
    SEC Form 4: Jenusaitis Matthew converted options into 1,042 units of Common Stock, increasing direct ownership by 22% to 5,884 units
  • PR1681d
    Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022